Superior SGC 深 滬
已收盤 08-07 16:00:00 美东时间
14.08
-0.050
-0.35%
華盛通- 最 高14.12
- 今 開13.88
- 成交量 5.69万股
- 最 低 13.42
- 昨 收 14.13
- 總市值 2.25亿
- 52周最高 14.5895
- 市盈率 靜 30.82
- 換手率 0.36%
- 52周最低 8.02
- 委 比 1.52%
- 總股本 1594.52万
- 歷史最高 26.47
- 量 比 0.65
- 振 幅 4.95%
- 歷史最低 2.84
- 每 手 1
- 風險率 1.44%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Superior Plus declares CAD 0.045 dividend
Superior Plus (SUUIF) declares CAD 0.045/share quarterly dividend, in line with previous. Payable Oct. 15; for shareholders of record Sept. 29; ex-div Sept. 29. See SUUIF Dividend Scorecard, Yield Cha...
08-07 10:04
美股大行评级 | AMD、Arista Networks、Booking 、加特纳、Pinterest、科力斯、Wayfair等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Precigen"买入"评级，目标价从14美元升至18美元；HC Wainwright & Co.：维持Sophia Genetics"买入"评级，目标价从12美元升至14美元
08-06 11:36
Superior Gr of Cos Q2 EPS $0.08 Misses $0.10 Estimate, Sales $147.836M Beat $142.863M Estimate
Superior Gr of Cos (NASDAQ:SGC) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.10 by 20 percent. This is a 20 percent decrease over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $147.836 million w...
08-04 19:07
Superior Gr of Cos Affirms FY2026 GAAP EPS Guidance of $0.54-$0.66 vs $0.61 Est; Affirms FY2026 Sales Guidance of $572.000M-$585.000M vs $578.973M Est
Superior Gr of Cos (NASDAQ:SGC) affirms FY2026 GAAP EPS guidance from $0.54-$0.66 to $0.54-$0.66 vs $0.61 analyst estimate. Affirms FY2026 sales outlook from $572.000 million-$585.000 million to $572.000 million-$585.000 million vs $578.973 million estimate.
08-04 19:05
Dianthus Therapeutics Announces DNTH312, a First-In-Class, Next-Generation Bifunctional Fusion Protein Combining Claseprubart and TACI, for Severe Autoimmune Diseases
Dianthus Therapeutics announced DNTH312, a first-in-class bifunctional fusion protein targeting aC1s and BAFF/APRIL, with the goal of enhancing clinical efficacy in autoimmune diseases. DNTH312 demonstrates comparable potency to claseprubart, with a similar non-human primate half-life, and shows similar Ig reductions to povetacicept. It aims to expand Dianthus' leadership in neuromuscular diseases and address broader patient populations. DNTH312 ...
08-04 11:00
Austral Tables Superior $80m Bid for Hammer Metals, Triggering Larvotto Match Period
The latest announcement is out from Austral Resources Australia Limited ( ($AU:...
08-03 07:12
Enbridge pipeline must be moved from Wisconsin tribal land, U.S. appeals court rules
Enbridge's (ENB) Line 5 oil pipeline is liable for trespassing on the Bad River Reservation in Wisconsin, the 7th U.S. Circuit Court of Appeals ruled Thursday, but the court gave the company more tim...
07-31 06:45
MasTec falls after guidance cut overshadows record quarter
MasTec (MTZ) shares fell 16% in extended trading Thursday after the infrastructure construction company raised its full-year revenue and adjusted earnings outlook, though the updated forecasts fell sh...
07-31 05:16
Edison argues idle transmission tower shields it from L.A. wildfire liability
Southern California Edison (EIX) is urging a judge not to find the company liable for property damages from a 2025 Los Angeles wildfire in part because the transmission tower where the fire allegedly ...
07-28 23:38
Superior Group of Companies to Announce Second Quarter 2026 Results
Superior Group of Companies, Inc. (SGC) will release its Q2 2026 financial results on August 4, 2026, before market open. CEO Michael Benstock and CFO Mike Koempel will host a teleconference at 8:00 am ET that day to discuss the results. The live webcast and replay are available on the company's investor relations website. Participants can join via phone using the provided dial-in numbers. A replay will be available until August 18, 2026. SGC, es...
07-21 20:05
